Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
-
-
Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
-
UNICEF and Moderna announced long term agreement to supply vaccine on behalf of the COVAX facility
On Jun. 2, 2021, UNICEF announced it had signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the…
-
Vaxxas and collaborators revealed potential of Vaxxas’ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxas’ novel high-density microarray patch (HD-MAP)…
-
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
-
WHO validated Sinovac COVID-19 vaccine for emergency use
On Jun. 1, 2021, World Health Organization (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries,…
-
HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | WHO
WHO $50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
-
NIH clinical trial evaluating mixed COVID-19 vaccine schedules began
On Jun. 1, 2021, the National Institutes of Health (NIH) announced that it had started a Phase 1/2…
-
Moderna announced rolling submission of Biologics License Application with FDA for COVID-19 vaccine
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
-
Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
-
Omeros announced preliminary results from additional critically Ill COVID-19 patients treated with narsoplimab
Omeros announced preliminary results from the second cohort of critically ill COVID-19 patients treated with narsoplimab in Bergamo,…
-
Sanofi and GSK initiated global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
-
University of Oxford launched Pandemic Sciences Centre
On May 27, 2021, the University of Oxford has today announced the launch of a new centre of…
-
Altimmune demonstrated strong neutralization of South African variant in preclinical study of intranasal AdCOVID
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
-
ImmunityBio expanded South African trials of T-cell-based COVID-19 vaccine candidate as ‘Universal Boost’ in vaccinated subjects
On May 25, 2021, ImmunityBio announced two South African studies to examine the potential for using its hAd5…
-
Moderna announced TeenCOVE study of COVID-19 vaccine in adolescents met primary endpoint
On May 25, 2021, Moderna announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | FDA | Infectious Disease | Therapeutics | Vaccine
The Wave
The Wave Cartoon Illustrates how unprepared the U.S. was when the COVID-19 wave hit our shores despite the…
-
Disease | Infectious Disease | Vaccine | WHO
WHO and Switzerland launched global BioHub for pathogen storage, sharing and analysis
On May 24, 2021, the World Health Organization (WHO) and the Swiss Confederation signed a Memorandum of Understanding…
-
Moderna and Aldevron announced expanded partnership for mRNA vaccine and therapeutic pipeline
On May 24, 2021, Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, the…
-
Study initiated exploring coadministration of 20-valent pneumococcal conjugate vaccine with third dose of Pfizer-BioNTech COVID-19 vaccine
On May 24, 2021, Pfizer announced that the first enrolled subjects had received their immunizations as part of…
-
Moderna and Samsung Biologics announced agreement for manufacturing of Moderna’s COVID-19 vaccine
On May 22, 2021, Moderna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung…
-
Novavax announced MOU to explore expansion of COVID-19 vaccine activities in South Korea
On May 22, 2021, Novavax announced the signing of a non-binding memorandum of understanding (MoU) with the Ministry…
-
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
-
G20 leaders boosted support of the Access to COVID-19 Tools Accelerator
On May 21, 2021, world leaders the Global Health Summit adopted an agenda to overcome the COVID-19 pandemic,…
-
Japan’s Ministry of Health, Labour and Welfare approved Moderna’s COVID-19 vaccine
On May 21, 2021, Moderna announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan granted…
-
Complete trial results of Novavax COVID-19 investigational vaccine posted to preprint server medRxiv
On May 21, 2021, Novavax announced that the full results from the Phase 3, randomized, observer-blinded, placebo-controlled trial…
-
Novavax announced participation in mix-and-match COVID-19 vaccine booster trial in the United Kingdom
On May 21, 2021, Novavax announced participation in a mix-and-match (vaccine interchangeability) COVID-19 vaccine booster trial that led…
-
Gavi signed agreement with Johnson & Johnson for supply of its COVID-19 vaccine to COVAX
On May 21, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Johnson…
-
Merck announced positive topline results from phase 3 pediatric studies for investigational 15-valent pneumococcal conjugate vaccine
On May 20, 2021, Merck announced V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, met its primary immunogenicity…
